Sr. Vice President, Regulatory Affairs, Clinical Development & Quality Assurance
I always speak good of you, your company and the efficiency which is exhibited in addition to the optimal costs.
Director Research & Development
I wanted to let you know that we received FDA approval of the our Argatroban NDA yesterday. On behalf of our company, I’d like to also thank you and the entire Sannova team for your efforts in supporting the studies under very tight timelines - we did not receive a single question on the clotting studies or the associated Sannova validation/testing during the review. Thank you once again for your contributions and congratulations.I look forward to working with Sannova on future projects.
Chief Scientific Officer
We received confirmation from our Regulatory Affairs group that the file was received by the FDA. Many thanks to your entire team for their hard work and dedication on these studies! Your efforts have allowed us to submit on the same day that our stability data was available.
Executive Director Clinical Research and Development